HORIBA Medical has over 1,100 employees across its sites and subsidiaries. It produces 7,500 instruments a year and it is now over 10,000 tons of reagents produced annually.
HORIBA Medical also benefits from technologies patented by the HORIBA Group and the synergies between its 13 research centers throughout the world.


Since joining the Japanese Group HORIBA in 1996, company sales has continued to grow exponentially to reach €144.8 million in 2011.

 

 

Key indicators

  • Over 1,100 employees
  • 4 production centers (Japan, China, France, Brazil)
  • 2 R&D centers (Japan, France)
  • Around 100 distributors
  • 13 local/direct operations
  • Around 30,000 laboratories supplied worldwide

3 May 2019 - The XXX IInd International Symposium on Technological Innovation in Laboratory Hematology

Read more

new Yumizen GDDi 2 (D-Dimer) reagent kit

20 Mar 2019 - New Yumizen GDDi 2 (D-Dimer) reagent kit for DVT and Pulmonary Embolism diagnosis HORIBA UK Ltd,...

Read more

14 Feb 2019 - 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine

Read more